Energy-stress-mediated AMPK activation inhibits ferroptosis

Nat Cell Biol. 2020 Feb;22(2):225-234. doi: 10.1038/s41556-020-0461-8. Epub 2020 Feb 6.

Abstract

Energy stress depletes ATP and induces cell death. Here we identify an unexpected inhibitory role of energy stress on ferroptosis, a form of regulated cell death induced by iron-dependent lipid peroxidation. We found that ferroptotic cell death and lipid peroxidation can be inhibited by treatments that induce or mimic energy stress. Inactivation of AMP-activated protein kinase (AMPK), a sensor of cellular energy status, largely abolishes the protective effects of energy stress on ferroptosis in vitro and on ferroptosis-associated renal ischaemia-reperfusion injury in vivo. Cancer cells with high basal AMPK activation are resistant to ferroptosis and AMPK inactivation sensitizes these cells to ferroptosis. Functional and lipidomic analyses further link AMPK regulation of ferroptosis to AMPK-mediated phosphorylation of acetyl-CoA carboxylase and polyunsaturated fatty acid biosynthesis. Our study demonstrates that energy stress inhibits ferroptosis partly through AMPK and reveals an unexpected coupling between ferroptosis and AMPK-mediated energy-stress signalling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • A549 Cells
  • AMP-Activated Protein Kinases / antagonists & inhibitors
  • AMP-Activated Protein Kinases / genetics*
  • AMP-Activated Protein Kinases / metabolism
  • Acetyl-CoA Carboxylase / genetics*
  • Acetyl-CoA Carboxylase / metabolism
  • Animals
  • Cell Line, Tumor
  • Cyclohexylamines / pharmacology
  • Embryo, Mammalian
  • Energy Metabolism / drug effects
  • Energy Metabolism / genetics
  • Fatty Acids, Unsaturated / biosynthesis
  • Ferroptosis / drug effects
  • Ferroptosis / genetics*
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Gene Expression Regulation
  • Glucose / deficiency
  • Glucose / pharmacology
  • Humans
  • Iron / metabolism
  • Kidney / drug effects
  • Kidney / enzymology*
  • Kidney / pathology
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / genetics*
  • MCF-7 Cells
  • Mice
  • Mice, Transgenic
  • Phenylenediamines / pharmacology
  • Phosphorylation
  • Piperazines / antagonists & inhibitors
  • Piperazines / pharmacology
  • Primary Cell Culture
  • Pyrazoles / pharmacology
  • Pyrimidines / pharmacology
  • Reperfusion Injury / enzymology
  • Reperfusion Injury / genetics*
  • Reperfusion Injury / pathology
  • Signal Transduction
  • Stress, Physiological / drug effects
  • Stress, Physiological / genetics

Substances

  • Cyclohexylamines
  • Fatty Acids, Unsaturated
  • Phenylenediamines
  • Piperazines
  • Pyrazoles
  • Pyrimidines
  • erastin
  • ferrostatin-1
  • dorsomorphin
  • Iron
  • AMP-Activated Protein Kinases
  • Acetyl-CoA Carboxylase
  • Glucose